PER

0.00%

10.5¢ percheron therapeutics limited

Wrong Boomyi have already posted my disgust re CR .on Hc But...

First 54 Last

Share
Profile

Follow
itsagas

13,421 Posts.

1439

12/10/23

23:01

Post #: 70319355
Share

Originally posted by BoomCrashOffera: ↑

Okay, so my experiment in itsagas abstinence lasted a little over 48 hours. It did save the forum from my reactive posting, which I get. But it wasn’t great for me in understanding what the heck everyone was talking about. Trying to follow a thread was like watching a movie with a prominent character muted.

So itsa is the bastion of support for the “elected board” and sole protector of their infallibleness.

Before going any further, I’d just like to say I respect the Board, think that CG is doing a admirable job so far, and like every shareholder here, have high hopes for the future with the board and management changes that have recently taken place.

But don’t get fooled by Itsagas’s professed support for anything that Board and management do as being beyond reproach. His email he posted to us here (sent to the previous CEO and Board member) over the “disgrace” of the 2021 CR shows that what he really means is either:

1. Only itsagas is allowed to criticise the “elected board”,

And/or

2. You’re allowed to criticise the “elected board” but only in private communication - not on HC, which itsa regards as an ANP promotional propaganda machine that is part of his “business”

I’ll post the itsa-Diamond email in a following post, apologising to most who are already aware of it.

After all, one of the prime responsibilities of an ASX junior biotech board is to arrange and structure (at least approve of, given input from external advisors/investment banks), a capital raise.

Expand

Wrong Boomy
i have already posted my disgust re CR .on Hc
But then again how many times do have to repeat myself.

ANP Price at posting: 6.7¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 32 more messages in this thread...

First 54 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 10.5¢		Change 0.000(0.00%)		Mkt cap ! $94.66M

Open	High	Low	Value	Volume
10.5¢	10.5¢	9.8¢	$58.09K	574.8K

Buyers (Bids)

No.	Vol.	Price($)
1	38503	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	194063	5

View Market Depth

No.	Vol.	Price($)
1	100000	0.099
2	108491	0.098
1	30927	0.097
1	10004	0.096
3	162157	0.095

Price($)	Vol.	No.
0.105	194063	5
0.110	254663	3
0.115	1334300	6
0.120	381142	9
0.125	110429	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PER (ASX) Chart

Wrong Boomyi have already posted my disgust re CR .on Hc But...

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Wrong Boomyi have already posted my disgust re CR .on Hc But...

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News